Esperion Therapeutics, Inc. (LON:0IIM)
1.815
-0.060 (-3.20%)
At close: Feb 21, 2025
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of 283.67 million as of February 21, 2025. Its market cap has decreased by -18.79% in one year.
Market Cap
283.67M
Enterprise Value
381.96M
Revenue
220.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.82
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from 137.93M to 283.67M, an increase of 105.67%. That is a compound annual growth rate of 6.38%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 179.71B |
GSK plc | 59.06B |
Haleon | 34.94B |
Smith & Nephew | 8.87B |
Hikma Pharmaceuticals | 5.06B |
ConvaTec Group | 4.94B |
HUTCHMED (China) | 2.06B |
Oxford Nanopore Technologies | 1.26B |